Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

NVAX

Live52w high -25.8%

Annual Quarterly

Core line items from NVAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Log in Get Started

Annual Quarterly

Entity: NOVAVAX, INC.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-04	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$52.12M	$139.51M	$1.12B	$976.34M	$905.89M
Operating Income	Not available	$-15.43M	$452.80M	$438.56M	$616.58M
Net Income	Not available	$-9.49M	$440.30M	$422.77M	$625.15M
EPS (Diluted)	$-0.41	$-0.06	$2.58	$2.53	$3.55
Total Assets	Not available	$1.04B	$1.18B	$1.18B	$1.34B
Total Liabilities	Not available	$1.19B	$1.30B	$1.34B	$1.30B
Cash & Equivalents	Not available	$228.36M	$240.63M	$268.02M	$253.74M
Free Cash Flow OCF − CapEx	Not available	$-33.69M	$-250.19M	$-208.64M	$-314.43M
Shares Outstanding	Not available	164.42M	162.58M	162.47M	162.16M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from NVAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -25.8%

Entity: NOVAVAX, INC.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-08-04	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$52.12M	$139.51M	$1.12B	$976.34M	$905.89M
Operating Income	Not available	$-15.43M	$452.80M	$438.56M	$616.58M
Net Income	Not available	$-9.49M	$440.30M	$422.77M	$625.15M
EPS (Diluted)	$-0.41	$-0.06	$2.58	$2.53	$3.55
Total Assets	Not available	$1.04B	$1.18B	$1.18B	$1.34B
Total Liabilities	Not available	$1.19B	$1.30B	$1.34B	$1.30B
Cash & Equivalents	Not available	$228.36M	$240.63M	$268.02M	$253.74M
Free Cash Flow OCF − CapEx	Not available	$-33.69M	$-250.19M	$-208.64M	$-314.43M
Shares Outstanding	Not available	164.42M	162.58M	162.47M	162.16M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.